Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Niela K. Pomernacki"'
Autor:
Teresa N. Harrison, James V. Freeman, Anthony E Steimle, Kristi Reynolds, Natalia Udaltsova, Daniel E. Singer, Niela K. Pomernacki, Margaret C. Fang, Alan S. Go, Leila H. Borowsky
Publikováno v:
Circulation. Arrhythmia and electrophysiology, vol 8, iss 1
Background— Digoxin remains commonly used for rate control in atrial fibrillation, but limited data exist supporting this practice and some studies have shown an association with adverse outcomes. We examined the independent association between dig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e5ae64abe9fa6945c0b396a247ddc4
https://doi.org/10.1161/circep.114.002292
https://doi.org/10.1161/circep.114.002292
Autor:
Niela K. Pomernacki, Daniel E. Singer, Margaret C. Fang, Yuchiao Chang, Alan S. Go, Leila H. Borowsky, Natalia Udaltsova
Publikováno v:
Stroke. 43:1795-1799
Background and Purpose— Prescribing warfarin for atrial fibrillation depends in large part on the expected reduction in ischemic stroke risk versus the expected increased risk of intracranial hemorrhage (ICH). However, the anticoagulation decision
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386cdf2cd775e830586018f6f5ec3f87
https://doi.org/10.1161/strokeaha.111.630731
https://doi.org/10.1161/strokeaha.111.630731
Autor:
Niela K. Pomernacki, Natalia Udaltsova, Margaret C. Fang, Daniel E. Singer, Alan S. Go, Yuchiao Chang, Leila H. Borowsky
Publikováno v:
Journal of the American College of Cardiology. 58:395-401
Objectives The purpose of this study was to develop a risk stratification score to predict warfarin-associated hemorrhage. Background Optimal decision making regarding warfarin use for atrial fibrillation requires estimation of hemorrhage risk. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8527428af08d7ca2c7dac358a9b7e3
https://doi.org/10.1016/j.jacc.2011.03.031
https://doi.org/10.1016/j.jacc.2011.03.031
Autor:
Yuchiao Chang, Alan S. Go, Niela K. Pomernacki, Margaret C. Fang, Daniel E. Singer, Natalia Udaltsova, Leila H. Borowsky
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 2:297-304
Background— Randomized trials and observational studies support using an international normalized ratio (INR) target of 2.0 to 3.0 for preventing ischemic stroke in atrial fibrillation. We assessed whether the INR target should be adjusted based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea2e61e0405daee95b58a2a4220effa
https://doi.org/10.1161/circoutcomes.108.830232
https://doi.org/10.1161/circoutcomes.108.830232
Autor:
Daniel E. Singer, Leila H. Borowsky, Alan S. Go, Yuchiao Chang, Margaret C. Fang, Niela K. Pomernacki
Publikováno v:
Journal of the American College of Cardiology. 51(8):810-815
Objectives We assessed 5 risk stratification schemes for their ability to predict atrial fibrillation (AF)–related thromboembolism in a large community-based cohort. Background Risk schemes can help target anticoagulant therapy for patients at high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b45e7da72506d2a9705ebfdef12c9b2
Autor:
Margaret C. Fang, Niela K. Pomernacki, Natalia Udaltsova, Daniel E. Singer, Alan S. Go, Yuchiao Chang, Leila H. Borowsky
Publikováno v:
Neurology, vol 82, iss 12
Objectives: While the short-term impact of atrial fibrillation–related stroke has been well studied, surprisingly little is known about its long-term effect on survival. Methods: We followed 13,559 patients with atrial fibrillation for a median of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9da2cacdcc77a2ebcb34e93a5ba6709e
https://escholarship.org/uc/item/0wr1m8dn
https://escholarship.org/uc/item/0wr1m8dn
Autor:
Niela K. Pomernacki, Leila H. Borowsky, Margaret C. Fang, Daniel E. Singer, Kristi Reynolds, Yuchiao Chang, Natalia Udaltsova, Alan S. Go
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background More accurate and reliable stroke risk prediction tools are needed to optimize anticoagulation decision making in patients with atrial fibrillation ( AF ). We developed a new AF stroke prediction model using the original A nticoagulation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a70007bf746ddfb8fb7efff68cd1f85
https://pubmed.ncbi.nlm.nih.gov/23782923
https://pubmed.ncbi.nlm.nih.gov/23782923
Autor:
Daniel E Singer, Yuchiao Chang, Leila H Borowsky, Margaret C Fang, Niela K Pomernacki, Natalia Udaltsova, Kristi Reynolds, Alan S Go
Publikováno v:
Stroke. 43
Objective: Evaluating stroke risk in patients with atrial fibrillation (AF) is central to the anticoagulation decision. Our goal was to develop and internally validate a more accurate model to predict stroke in AF. Methods: We analyzed all person-tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8cb390fbd46ab26fd2915ca1a840b93
https://doi.org/10.1161/str.43.suppl_1.a186
https://doi.org/10.1161/str.43.suppl_1.a186
Autor:
Margaret C, Fang, Alan S, Go, Yuchiao, Chang, Leila H, Borowsky, Niela K, Pomernacki, Natalia, Udaltsova, Daniel E, Singer
The purpose of this study was to develop a risk stratification score to predict warfarin-associated hemorrhage.Optimal decision making regarding warfarin use for atrial fibrillation requires estimation of hemorrhage risk.We followed up 9,186 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::00ad647896ab3c52a842f0e63198838d
https://europepmc.org/articles/PMC3175766/
https://europepmc.org/articles/PMC3175766/
Autor:
Niela K. Pomernacki, Alan S. Go, Natalia Udaltsova, Daniel E. Singer, Yuchiao Chang, Margaret C. Fang, Leila H. Borowsky
Background— Although warfarin is widely recommended to prevent atrial fibrillation-related thromboembolism, many eligible patients do not take warfarin. The objective of this study was to describe factors associated with warfarin discontinuation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba5ac32c41323e5dc893a8e58e581c9
https://europepmc.org/articles/PMC3063305/
https://europepmc.org/articles/PMC3063305/